NM_004304.5:c.3182G>A

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PP3BP6BS2

The NM_004304.5(ALK):​c.3182G>A​(p.Arg1061Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000961 in 1,613,666 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1061W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000098 ( 1 hom. )

Consequence

ALK
NM_004304.5 missense

Scores

8
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2O:1

Conservation

PhyloP100: 6.00

Publications

8 publications found
Variant links:
Genes affected
ALK (HGNC:427): (ALK receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
ALK Gene-Disease associations (from GenCC):
  • neuroblastoma, susceptibility to, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 2-29223519-C-T is Benign according to our data. Variant chr2-29223519-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 133470.
BS2
High AC in GnomAd4 at 12 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004304.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
NM_004304.5
MANE Select
c.3182G>Ap.Arg1061Gln
missense
Exon 20 of 29NP_004295.2
ALK
NM_001353765.2
c.-23G>A
5_prime_UTR
Exon 1 of 10NP_001340694.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
ENST00000389048.8
TSL:1 MANE Select
c.3182G>Ap.Arg1061Gln
missense
Exon 20 of 29ENSP00000373700.3
ALK
ENST00000638605.1
TSL:1
n.59G>A
non_coding_transcript_exon
Exon 2 of 11
ALK
ENST00000618119.4
TSL:5
c.2051G>Ap.Arg684Gln
missense
Exon 19 of 28ENSP00000482733.1

Frequencies

GnomAD3 genomes
AF:
0.0000855
AC:
13
AN:
152124
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000643
AC:
16
AN:
248998
AF XY:
0.000104
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000447
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000978
AC:
143
AN:
1461424
Hom.:
1
Cov.:
34
AF XY:
0.000109
AC XY:
79
AN XY:
727012
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33476
American (AMR)
AF:
0.00
AC:
0
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39694
South Asian (SAS)
AF:
0.000336
AC:
29
AN:
86236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53062
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5742
European-Non Finnish (NFE)
AF:
0.0000944
AC:
105
AN:
1111982
Other (OTH)
AF:
0.0000994
AC:
6
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152242
Hom.:
0
Cov.:
33
AF XY:
0.000107
AC XY:
8
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41546
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000120
Hom.:
0
Bravo
AF:
0.0000642
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000988
AC:
12
Asia WGS
AF:
0.000289
AC:
2
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions as Germline

Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
2
-
Neuroblastoma, susceptibility to, 3 (2)
-
1
-
not provided (1)
-
-
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.039
T
BayesDel_noAF
Uncertain
0.010
CADD
Pathogenic
35
DANN
Uncertain
1.0
DEOGEN2
Benign
0.23
T
Eigen
Benign
0.050
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.86
D
M_CAP
Benign
0.057
D
MetaRNN
Uncertain
0.58
D
MetaSVM
Benign
-0.69
T
MutationAssessor
Benign
1.1
L
PhyloP100
6.0
PrimateAI
Uncertain
0.63
T
PROVEAN
Uncertain
-2.7
D
REVEL
Uncertain
0.48
Sift
Benign
0.053
T
Sift4G
Benign
0.075
T
Polyphen
0.40
B
Vest4
0.85
MVP
0.95
MPC
0.24
ClinPred
0.22
T
GERP RS
4.7
PromoterAI
-0.11
Neutral
Varity_R
0.21
gMVP
0.61
Mutation Taster
=72/28
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.57
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.57
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72852032; hg19: chr2-29446385; COSMIC: COSV66572475; API